These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 3677224)
1. Inhibitors of the arachidonate cascade from Allium chinense and their effect on in vitro platelet aggregation. Goda Y; Shibuya M; Sankawa U Chem Pharm Bull (Tokyo); 1987 Jul; 35(7):2668-74. PubMed ID: 3677224 [No Abstract] [Full Text] [Related]
3. Differential effects of cyclo-oxygenase inhibitors and thromboxane synthase inhibitors on rabbit platelet aggregation: evidence for the importance of prostaglandin endoperoxides as mediators in arachidonate-induced aggregation but not in collagen-induced aggregation. Wallis RB; Zelaschi D Biochem Soc Trans; 1980 Dec; 8(6):726-7. PubMed ID: 6780392 [No Abstract] [Full Text] [Related]
6. Antagonism of hyperthermogenic agents by L 8027, an inhibitor of prostaglandin and thromboxane synthetase. Clark WG; Lipton JM Proc Soc Exp Biol Med; 1979 Apr; 160(4):473-6. PubMed ID: 313058 [No Abstract] [Full Text] [Related]
7. An overview of antiplatelet and antithrombotic drugs. Verstraete M; Dejana E; Fuster V; Lapetina E; Moncada S; Mustard JF; Tans G; Vargaftig BB Haemostasis; 1985; 15(2):89-99. PubMed ID: 3159632 [No Abstract] [Full Text] [Related]
8. Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets. Naito J; Komatsu H; Ujiie A; Hamano S; Kubota T; Tsuboshima M Eur J Pharmacol; 1983 Jul; 91(1):41-8. PubMed ID: 6413227 [TBL] [Abstract][Full Text] [Related]
9. Requirement of ADP for arachidonic acid-induced platelet aggregation: studies with selective thromboxane-synthase inhibitors. Cerletti C; Minoldo S; Bucchi F; Del Maschio A; de Gaetano G Biochem Pharmacol; 1986 Apr; 35(7):1201-3. PubMed ID: 3083818 [No Abstract] [Full Text] [Related]
10. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism. Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816 [TBL] [Abstract][Full Text] [Related]
11. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour. Parry MJ Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):23S-29S. PubMed ID: 6401997 [TBL] [Abstract][Full Text] [Related]
12. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro. De Clerck F; Beetens J; de Chaffoy de Courcelles D; Freyne E; Janssen PA Thromb Haemost; 1989 Feb; 61(1):35-42. PubMed ID: 2546278 [TBL] [Abstract][Full Text] [Related]
13. Potentiation by dazoxiben, a thromboxane synthetase inhibitor, of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin. Bertele V; De Gaetano G Eur J Pharmacol; 1982 Dec; 85(3-4):331-3. PubMed ID: 6295787 [TBL] [Abstract][Full Text] [Related]
14. A comparison of imidazole and 9,11-azoprosta-5,13-dienoic acid. Two selective thromboxane synthetase inhibitors. Fitzpatrick FA; Gorman RR Biochim Biophys Acta; 1978 Mar; 539(2):162-72. PubMed ID: 629996 [TBL] [Abstract][Full Text] [Related]
15. Benzodiazepine analogues inhibit arachidonate-induced aggregation and thromboxane synthesis in human platelets. Fonlupt P; Croset M; Lagarde M Br J Pharmacol; 1990 Dec; 101(4):920-4. PubMed ID: 1964822 [TBL] [Abstract][Full Text] [Related]